The CRISPR genome-editing tool helps scientists to make changes in specific genes and it has two components, including a homing device to a specific section of DNA (guide-RNA)
Under the deal, Astellas is responsible to develop and commercialize Immunomic’s vaccine candidate JRC2-LAMP-vax, which is designed to treat allergies induced by Japanese red cedar pollen. Both the
Endo president and CEO Rajiv De Silva said: "This strategic transaction enhances the organic growth of our branded pharmaceuticals business by adding a broad range of high quality
In order to manage the regulatory submission to the Australian Therapeutics Goods Administration (TGA) and the up-and-coming clinical trial, ISCO has established an Australian subsidiary named Cyto Therapeutics.
Imbruvica is an once-daily oral therapy that inhibits a protein called Bruton’s tyrosine kinase (BTK). It also secured breakthrough therapy designation for WM from the FDA and is
Tarextumab is a fully human monoclonal antibody that targets the Notch2 and Notch3 receptors. Currently, the company is enrolling patients in a randomized Phase II trial of tarextumab
The once-daily Evotaz is a combination of the protease inhibitor atazanavir, marketed as Reyataz (atazanavir 200mg/300mg) capsules, and cobicistat, a pharmacokinetic enhancer marketed by Gilead Sciences. According to
Facilitated by Johnson & Johnson Innovation, the deal grants Janssen an exclusive, worldwide license for an orally administered biopharmaceutical product candidate specifically designed to treat IBS. AMT uses
In the trial, a total of 111 patients were enrolled globally from sites in the US, Eastern Europe and Asia. The company said that data, secured from the
The company said that signaling components of the PI3K pathway are central regulators of cell proliferation, growth, differentiation, survival and angiogenesis. About 80% of tumor types have been
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.